latest issueLatest Issue
  • Extreme vision loss

    Friday, July 6, 2018

    Undetected toxic batches of PFO and related products cause extreme vision loss

  • Ophthalmologica

    Friday, July 6, 2018

    Volume 240 Issue 1

  • New treatments for uveitis arsenal

    Friday, July 6, 2018

    Biologic response modifiers offer new options for third-line treatment

  • Retinal detachment surgery

    Friday, July 6, 2018

    Databases highlight risk factors for failure in detachment surgery

  • Stem cell implant study

    Friday, July 6, 2018

    Human stem-cell-derived RPE transplants show good safety with hints of functional improvement

  • Visual acuity and uveitis

    Friday, June 1, 2018

    Accurate and timely diagnosis of uveitis can be a life-saving measure

  • 12-week regimen easier for patients and physicians

    Tuesday, May 1, 2018

    AMD sufferers provided relief from the stress and inconvenience of monthly injections

  • Personalised therapies

    Tuesday, May 1, 2018

    Systemic and ophthalmic biomarkers may facilitate a better understanding of diabetic retinopathy

  • Anti-VEGF comparison

    Tuesday, May 1, 2018

    Ranibizumab and aflibercept both effective in RIVAL study for nAMD

  • DME progression

    Tuesday, April 3, 2018

    Predictors identified for progression in diabetic retinopathy help guide who needs treatment most

Latest Articles

escrs members advert